Genetic Technologies Ltd. (GENE)
0.765
0.00 (0.00%)
USD |
NASDAQ |
Jun 26, 16:00
Genetic Technologies Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2024 | 1.798M |
| June 30, 2024 | 1.862M |
| December 31, 2023 | 3.998M |
| June 30, 2023 | 3.999M |
| December 31, 2022 | -0.3008M |
| June 30, 2022 | -0.2006M |
| December 31, 2021 | 5.875M |
| June 30, 2021 | 10.57M |
| December 31, 2020 | 14.00M |
| June 30, 2020 | 12.11M |
| December 31, 2019 | 4.027M |
| June 30, 2019 | 2.207M |
| December 31, 2018 | 0.9756M |
| June 30, 2018 | -0.0077M |
| December 31, 2017 | 0.0071M |
| June 30, 2017 | 5.364M |
| December 31, 2016 | 5.350M |
| June 30, 2016 | -0.0012M |
| December 31, 2015 | 15.91M |
| June 30, 2015 | 17.88M |
| December 31, 2014 | 1.922M |
| June 30, 2014 | 10.90M |
| December 31, 2013 | 11.29M |
| June 30, 2013 | 0.4438M |
| Date | Value |
|---|---|
| December 31, 2012 | 0.015M |
| June 30, 2012 | 11.24M |
| December 31, 2011 | 11.12M |
| June 30, 2011 | -0.3294M |
| December 31, 2010 | 0.6794M |
| June 30, 2010 | 0.6967M |
| December 31, 2009 | -0.1562M |
| June 30, 2009 | -0.1384M |
| December 31, 2008 | -0.3186M |
| June 30, 2008 | -0.4933M |
| December 31, 2007 | -0.4076M |
| June 30, 2007 | -0.4086M |
| December 31, 2006 | -0.4306M |
| June 30, 2006 | -0.3357M |
| December 31, 2005 | 9.449M |
| June 30, 2005 | 9.963M |
| December 31, 2004 | 0.8608M |
| June 30, 2004 | 8.039M |
| December 31, 2003 | 7.542M |
| June 30, 2003 | 0.0105M |
| December 31, 2002 | 0.0765M |
| June 30, 2002 | 0.2838M |
| December 31, 2001 | 0.1549M |
| June 30, 2001 | -0.0063M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (TTM) Benchmarks
| Immutep Ltd. | -0.1245M |
| CSL Ltd. | -2.929B |
| Polynovo Ltd. | -1.235M |
| Actinogen Medical Ltd. | -0.2967M |
| Genetic Technologies Ltd. | -- |